Citation Impact
Citing Papers
Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by Vα14 i NKT Cells
2009
Loss of T Cell and B Cell Quiescence Precedes the Onset of Microbial Flora-Dependent Wasting Disease and Intestinal Inflammation in Gimap5-Deficient Mice
2010 StandoutNobel
NKT Cell Activation Mediates Neutrophil IFN-γ Production and Renal Ischemia-Reperfusion Injury
2007
Immunotherapy of cancer in 2012
2012
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
2005 StandoutNatureNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
Crystal Structure of the Murine Cytomegalovirus MHC-I Homolog m144
2006
Extravascular T-cell recruitment requires initiation begun by Vα14+ NKT cells and B-1 B cells
2004
The unique role of natural killer T cells in the response to microorganisms
2007
Ulcerative Colitis
2011 Standout
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Understanding the behavior of invariant NKT cells in autoimmune diseases
2007
Intranasal but not intravenous delivery of the adjuvant α‐galactosylceramide permits repeated stimulation of natural killer T cells in the lung
2011
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
The role of macrophages in skin homeostasis
2017
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Prolonged IFN-γ–producing NKT response induced with α-galactosylceramide–loaded DCs
2002 StandoutNobel
Peripheral CD4 T-Cell Depletion Is Not Sufficient to Prevent Ischemic Acute Renal Failure
2005
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria
2006 StandoutNobel
Targeting iNKT cells for the treatment of sickle cell disease
2011
Adoptive transfer of IL-10-secreting CD4+CD49b+ regulatory T cells suppresses ongoing arthritis
2009
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
2008
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Inflammatory Bowel Disease
2009 Standout
Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis
2004
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis
2008
The unconventional lifestyle of NKT cells
2002
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions
2009
Ulcerative colitis
2012 Standout
Invariant Natural Killer T Cells Suppress the Neutrophil Inflammatory Response in a Mouse Model of Cholestatic Liver Damage
2008
Immunity, Inflammation, and Cancer
2010 Standout
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Ulcerative colitis
2016 Standout
Recognition of lipid antigens by T cells
2005
Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide
2000
Cancer immunotherapy comes of age
2011 StandoutNature
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
Rheumatoid arthritis
2010 Standout
Microenvironmental regulation of metastasis
2008 Standout
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages
2007 StandoutNobel
Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor
2005
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
2011
Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade
2010
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Neutrophil recruitment and function in health and inflammation
2013 Standout
Soluble CD36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands and Acts as a Co-Receptor for TLR2
2009 StandoutNobel
Lipid microarrays identify key mediators of autoimmune brain inflammation
2005
Mutations Designed to Destabilize the Receptor-Bound Conformation Increase MICA-NKG2D Association Rate and Affinity
2007 StandoutNobel
Expansion and Hyperactivity of CD1d-Restricted NKT Cells during the Progression of Systemic Lupus Erythematosus in (New Zealand Black × New Zealand White)F1 Mice
2005
The Biology of NKT Cells
2006 Standout
Combination Therapy with Anti–CTLA-4 and Anti–PD-1 Leads to Distinct Immunologic Changes In Vivo
2014
Design of natural killer T cell activators: Structure and function of a microbial glycosphingolipid bound to mouse CD1d
2006
Innate Immune Recognition of Cancer
2015
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
The immunosuppressive tumour network: myeloid‐derived suppressor cells, regulatory T cells and natural killer T cells
2012
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Wound Healing: A Cellular Perspective
2018 Standout
Anatomy of CD1–lipid antigen complexes
2005
Cancer Genome Landscapes
2013 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Liver as a Lymphoid Organ
2009
Role of CD1d-Restricted NKT Cells in Microbial Immunity
2003
NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis
2007
Prolonging healthy aging: Longevity vitamins and proteins
2018
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice
2013 StandoutNobel
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
2010 StandoutNobel
PapA1 and PapA2 are acyltransferases essential for the biosynthesis of theMycobacterium tuberculosisvirulence factor Sulfolipid-1
2007 StandoutNobel
CD1: Antigen Presentation and T Cell Function
2004
Microglia activation in Niemann–Pick disease, type C1 is amendable to therapeutic intervention
2018
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
A Cell-Type Specific CD1d Expression Program Modulates Invariant NKT Cell Development and Function
2006
Structural Characterization of Mycobacterial Phosphatidylinositol Mannoside Binding to Mouse CD1d
2006
The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
2006 StandoutNobel
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
2006 StandoutNobel
Works of Ramesh Halder being referenced
Prevention of Autoimmunity by Targeting a Distinct, Noninvariant CD1d-reactive T Cell Population Reactive to Sulfatide
2004
PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
2009
Cross-Regulation between Type I and Type II NKT Cells in Regulating Tumor Immunity: A New Immunoregulatory Axis
2007
Resistance to Malarial Infection Is Achieved by the Cooperation of NK1.1+ and NK1.1− Subsets of Intermediate TCR Cells Which Are Constituents of Innate Immunity
2001
Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZB×NZW)F1 mice
2002
Cross‐regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens
2008
Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production
2015
Type II NKT cell–mediated anergy induction in type I NKT cells prevents inflammatory liver disease
2007
Anti-inflammatory therapies of amyotrophic lateral sclerosis guided by immune pathways.
2015
Essential Role of Extrathymic T Cells in Protection Against Malaria
2002
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity
2005
ω‐3 Supplementation increases amyloid‐β phagocytosis and resolvin D1 in patients with minor cognitive impairment
2015
Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease
2015
Characterization of NK cells and extrathymic T cells generated in the liver of irradiated mice with a liver shield
1998